Midostaurin Capsules are indicated to treat aggressive systemic mastocytosis, systemic mastocytosis with associated hematological neoplasm, or mast cell leukemia.
Rufinamide Oral Suspension is indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome in pediatric patients aged 1 year old and older, and in adults.